Novo plans to begin selling its FDA-approved weight-loss pill in the US in January following Oasis 4 trial results showing 13.6% average weight loss over 64 weeks, while Lilly's oral alternative, orforglipron, received expedited FDA review under a new 2025 voucher program and could be approved as soon as March, according to CEO Dave Ricks
Incorporate nutrient-dense foods: Focus on whole, nutrient-dense foods such as vegetables, fruits, whole grains, and healthy fats during your eating windows
Bn c th b gim nng lng nu ung whey trong khi tp luyn C th khin bn c cm gic kh tiu, au bng Tiu th qu nhiu protein hoc thc n dng lng trong khi tp luyn c th lm tng nguy c kh tiu nht l vi nhng ngi c tin s b tro ngc d dy, vim d dy, c vn v i trng,
The presenters noted this was more common in the higher doses of retatrutide and more common in patients already on anti-hypertension medications and tended to resolve after stopping the blood pressure medication or increasing fluid intake
Doctors use them to treat type 2 diabetes and, increasingly, obesity and related metabolic conditions
